![Jean-Marie Houle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jean-Marie Houle worked as Vice President-Research & Development at Chronogen, Inc. from 2006 to 2010.
Prior to that, he worked as a Principal at LAB Pharmacological Research International.
He received a graduate and doctorate degree from the University of Montréal.
Anciens postes connus de Jean-Marie Houle
Sociétés | Poste | Fin |
---|---|---|
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Directeur Technique/Scientifique/R&D | 23/04/2010 |
LAB Pharmacological Research International | Corporate Officer/Principal | - |
Formation de Jean-Marie Houle
University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Health Technology |
LAB Pharmacological Research International |